Current Edition

blood
Therapeutics V5 I4

New Understanding and New Tools to Improve the Effectiveness of Oncology Clinical Development (and Potentially Reduce Drug Costs)

High-priced prescription drugs have been making headlines for years, but soaring insurance premiums have put drug costs back in the spotlight. Ryan Mcguire, Rochelle gagg …

Continue Reading →
brain
Therapeutics V5 I4

Early-Phase Drug Development Strategies to Inform Decision-Making in the Viability of Novel CNS Compounds for Schizophrenia

The need to improve and accelerate the success of drug development in schizophrenia has resulted in the increased utilisation of novel pharmacodynamic methodologies that may readily translate …

Continue Reading →